ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,920, issued on June 9, was assigned to Neuronasal Inc. (Wexford, Pa.).
"Methods of administering glutathione precursors" was invented by Douglas A. Greene (Basking Ridge, N.J.) and Thomas I. Bradshaw (Wynnewood, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes methods of administering a pharmaceutical composition comprising a glutathione precursor and a thermoresponsive polymer via intranasal administration. In some embodiments, intranasal administration of the glutathione precursor can be used to treat a condition, for example, a central nervous system disorder."
The patent was filed on Feb. 21, 2023, under Applic...